Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of deoxyribonucleotide synthesis by pyridine carboxaldehyde thiosemicarbazones.

× No keyword cloud information.

4 in total

1. A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.

Authors: Amir Mortazavi; Yonghua Ling; Ludmila Katherine Martin; Lai Wei; Mitch A Phelps; Zhongfa Liu; Erica J Harper; S Percy Ivy; Xin Wu; Bing-Sen Zhou; Xiyong Liu; Deidre Deam; J Paul Monk; William J Hicks; Yun Yen; Gregory A Otterson; Michael R Grever; Tanios Bekaii-Saab
Journal: Invest New Drugs Date: 2012-07-31 Impact factor: 3.850

2. A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms.

Authors: Joshua F Zeidner; Judith E Karp; Amanda L Blackford; B Douglas Smith; Ivana Gojo; Steven D Gore; Mark J Levis; Hetty E Carraway; Jacqueline M Greer; S Percy Ivy; Keith W Pratz; Michael A McDevitt
Journal: Haematologica Date: 2013-12-20 Impact factor: 9.941

3. Inhibition of RNA-dependent DNA polymerase of Rous sarcoma virus by thiosemicarbazones and several cations.

Authors: W Levinson; A Faras; B Woodson; J Jackson; J M Bishop
Journal: Proc Natl Acad Sci U S A Date: 1973-01 Impact factor: 11.205

4. A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders.

Authors: Judith E Karp; Francis J Giles; Ivana Gojo; Lawrence Morris; Jacqueline Greer; Bonny Johnson; Mya Thein; Mario Sznol; Jennifer Low
Journal: Leuk Res Date: 2007-07-20 Impact factor: 3.156

4 in total